Importance: The under 5 years children of house hold contact with active tuberculosis cases is one of the main cause for the transmission of TB in pediatrics population, responsible for many complications and childhood mortality. Objective: To determine the factors influencing the practice and adherence of Isoniazid Prophylactic Therapy (IPT) among under 5 years children of house hold with cases of active pulmonary tuberculosis. Design: The study’s design was cross sectional. Setting: This study was conducted in TB referral units of the National Tuberculosis Control Program in Peshawar City. Participants: The study participants included patients with sputum-positive pulmonary TB having at least one under-5 years’ child in their household. Secondly, the doctors who were directly dealing with TB patients for diagnosis and treatments in referral units of the respective hospitals. Results: Most of the patients reported that doctors neither got some information about the under-5 years' children at their family nor to bring them for TB screening. Just 13.2% patients (36 out of 273) conceded that doctors mentioned them for prophylactic treatment with Isoniazid (INH) medication for their contact positive under-5years children. But only 4 of these 36 patients [(11.11%) 1.46%of the aggregate] completed the IPT course for their under-5 year children for 6 months duration. (Table 2) All the doctors claimed that they got information about the presence of under five years household contact in the family of TB patients. While the majority of the doctors/physicians (80%) had recognized that they neither requested the patients for screening from their family contact nor to give INH medication for their prophylaxis. This study showed that the practice of IPT was 13.2% and the adherence rate was just 11.11%, and the main factors for this poor result were poor healthcare system, lack of awareness, financial constraint and attitude of the patients. Conclusion: This study concludes that the extremely poor practice and adherence to isoniazid prophylactic therapy by doctors and patients in TB referral units in Peshawar city for under-5-year-old children of households with active tuberculosis patients was primarily caused by a lack of awareness, financial constraints, patient attitudes, and an inefficient healthcare system.
Published in | Journal of Family Medicine and Health Care (Volume 10, Issue 3) |
DOI | 10.11648/j.jfmhc.20241003.12 |
Page(s) | 51-59 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
House Hold, Contact Positive, Practice, Adherence
Count | Percentage | ||
---|---|---|---|
Age of the patient | <30 years | 50 | 18.3% |
30-40 years | 178 | 65.2% | |
>40 years | 45 | 16.5% | |
Total | 273 | 100% | |
Gender of the patient | Male | 211 | 77.3% |
Female | 62 | 22.7% | |
Total | 273 | 100% | |
Education status of the patient | Literate | 126 | 46.2% |
Illiterate | 147 | 53.8% | |
Total | 273 | 100% | |
Socioeconomic status of the patients | Lower class | 136 | 49.8% |
Middle class | 137 | 50.2% | |
Total | 273 | 100% | |
Marital status of the patient | Single | 26 | 9.5% |
Married | 229 | 83.9% | |
Other | 18 | 6.6% | |
Total | 273 | 100% | |
Number of children per household | <3 children | 71 | 26.0% |
children | 102 | 37.4% | |
>4 children | 100 | 36.6% | |
Total | 273 | 100% | |
Number of under 5 years children per house hold | <3children | 191 | 70.0% |
3-4 children | 82 | 30.0% | |
Total | 273 | 100% | |
Age of the Doctor | <30years | 3 | 30.0% |
>30years | 7 | 70.0% | |
Total | 10 | 100% | |
Gender of the doctor | Male | 8 | 80.0% |
Female | 2 | 20.0% | |
Total | 10 | 100% | |
Marital status of the doctor | Single | 3 | 30.0% |
Married | 7 | 70.0% | |
Others | 0 | 0.00% | |
Total | 10 | 1005 | |
Graduation status of the doctor | MBBS | 7 | 70.0% |
MD | 3 | 30.0% | |
Total | 10 | 100% | |
Post-graduation | Yes | 4 | 40.0% |
No | 6 | 60.0% | |
Total | 10 | 100% | |
Any special training for TB case management | Yes | 10 | 100% |
No | 0 | 0.00% | |
Total | 10 | 100% | |
Type of training for TB case management | Workshop | 7 | 70.0% |
Diploma | 3 | 30.0% | |
Degree | 0 | 0.00% | |
Total | 10 | 100% | |
Experience (as physician) | <6 years | 5 | 50.0% |
>6 years | 5 | 50.0% | |
Total | 10 | 100% | |
Experience working at TB referral unit | <6years | 8 | 80.0% |
>6years | 2 | 20.0% | |
Total | 10 | 100% |
Count | Percentage | ||
---|---|---|---|
Have ever your doctor asked you about under-5 year children at your household? | Yes | 40 | 14.7% |
No | 233 | 85.3% | |
Total | 273 | 100% | |
Did the doctor asked you to bring the child or children for TB screening? | Yes | 39 | 14.28% |
No | 234 | 85.72% | |
Total | 273 | 100% | |
Did your child or children diagnosed as TB? | Yes | 02 | 0.73% |
No | 271 | 99.27% | |
Total | 273 | 100% | |
Did you bring your children for prophylactic therapy | Yes | 36 | 13.2% |
No | 237 | 86.8% | |
Total | 273 | 100% | |
Did you complete 6 months treatment with NIH? | Yes | 04 | 11.11% |
No | 32 | 88.89% | |
Total | 36 | 100% | |
Why you did not bring your child for prophylactic therapy? | I was not aware nor advised by anyone | 167 | 61.18% |
Financial constraints | 98 | 35.89% | |
Not applicable | 08 | 2.93% | |
Total | 273 | 100% |
Count | Percentage | ||
---|---|---|---|
On average, how many patients you consult per day? | 30 | 5 | 50% |
35 | 3 | 30% | |
40 | 2 | 20% | |
Total | 10 | 100% | |
Do you ask routinely about the presence of under 5 year child at the household of TB | Yes | 10 | 100% |
No | 0.00 | 0.00% | |
total | 10 | 100% | |
Have you advised the members of household for screening? | Yes | 2 | 20% |
No | 8 | 80% | |
total | 10 | 100% | |
Even in case of non-compliance to screening, do you advise prophylaxes treatment for children? | Yes | 1 | 10% |
No | 9 | 90% | |
Total | 10 | 100% | |
Do you routinely provide NIH medicine to patients who have under-5 years children at their household? | Yes | 2 | 20% |
No | 8 | 80% | |
Total | 10 | 100% | |
Reason for not practicing the IPT? | No proper protocol | 6 | 60% |
Not applicable | 4 | 40% | |
Total | 10 | 100% | |
Reason for poor adherence? | Attitude of care giver | 2 | 20% |
Not applicable | 8 | 80% | |
Total | 10 | 100% |
[1] | Waksman SA. The conquest of tuberculosis: University of California Press; 2021. |
[2] | Riva MA. From milk to rifampicin and back again: history of failures and successes in the treatment for tuberculosis. The Journal of Antibiotics. 2014; 67(9): 661-5. |
[3] | Agarwal Y, Chopra RK, Gupta DK, Sethi RS. The tuberculosis timeline: Of white plague, a birthday present, and vignettes of myriad hues. Astrocyte. 2017; 4(1): 7. |
[4] | Koch R. “The Aetiology of Tuberculosis. An Address Delivered by Dr. Robert Koch before the Physiological Society of Berlin. Trans WDakley, MD Canada Medical and Surgical Journal. 1882: 649-55. |
[5] | Raviglione MC, Pio A. Evolution of WHO policies for tuberculosis control, 1948–2001. The Lancet. 2002; 359(9308): 775-80. |
[6] | Chetty S, Ramesh M, Singh-Pillay A, Soliman ME. Recent advancements in the development of anti-tuberculosis drugs. Bioorganic & medicinal chemistry letters. 2017; 27(3): 370-86. |
[7] | Long NH, Johansson E, Diwan VK, Winkvist A. Fear and social isolation as consequences of tuberculosis in VietNam: a gender analysis. Health policy. 2001; 58(1): 69-81. |
[8] | Lienhardt C, Glaziou P, Uplekar M, Lönnroth K, Getahun H, Raviglione M. Global tuberculosis control: lessons learnt and future prospects. Nature Reviews Microbiology. 2012; 10(6): 407-16. |
[9] | Sotgiu G, Sulis G, Matteelli A. Tuberculosis—A world health organization perspective. Tuberculosis and Nontuberculous Mycobacterial Infections. 2017: 211-28. |
[10] | Swaminathan S, Rekha B. Pediatric tuberculosis: global overview and challenges. Clinical infectious diseases. 2010; 50 (Supplement_3): S184-S94. |
[11] | Zar HJ, Connell TG, Nicol M. Diagnosis of pulmonary tuberculosis in children: new advances. Expert review of anti-infective therapy. 2010; 8(3): 277-88. |
[12] | Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B. Paediatric tuberculosis. The Lancet infectious diseases. 2008; 8(8): 498-510. |
[13] | Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Lombard C, Enarson DA, et al. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics. 2006; 118(5): e1350-e9. |
[14] | Marais B, Rabie H, Cotton M. TB and HIV in children–advances in prevention and management. Paediatric respiratory reviews. 2011; 12(1): 39-45. |
[15] | Mølhave M, Wejse C. Historical review of studies on the effect of treating latent tuberculosis. International Journal of Infectious Diseases. 2020; 92: S31-S6. |
[16] | Seid G, Tsedalu T, Ayele M. Adherence to isoniazid preventive therapy among under-five children in contact with adult bacteriologically confirmed pulmonary tuberculosis patients: a mixed-method study. International journal of microbiology. 2020; 2020. |
[17] | Shivaramakrishna H, Frederick A, Shazia A, Murali L, Satyanarayana S, Nair S, et al. Isoniazid preventive treatment in children in two districts of South India: does practice follow policy? The International journal of tuberculosis and lung disease. 2014; 18(8): 919-24. |
[18] | Black F, Amien F, Shea J. An assessment of the isoniazid preventive therapy programme for children in a busy primary healthcare clinic in Nelson Mandela Bay Health District, Eastern Cape Province, South Africa. South African medical journal. 2018; 108(3): 217-23. |
[19] | Egere U, Sillah A, Togun T, Kandeh S, Cole F, Jallow A, et al. Isoniazid preventive treatment among child contacts of adults with smear-positive tuberculosis in The Gambia. Public Health Action. 2016; 6(4): 226-31. |
[20] | Birungi FM, Graham SM, Uwimana J, Musabimana A, Van Wyk B. Adherence to isoniazid preventive therapy among child contacts in Rwanda: A mixed-methods study. PLoS One. 2019; 14(2): e0211934. |
[21] | De Muynck A, Siddiqi S, Ghaffar A, Sadiq H. Tuberculosis control in Pakistan: critical analysis of its implementation. J Pak Med Assoc. 2001; 51(1): 41-7. |
[22] | Organization WH. Best practices in child and adolescent tuberculosis care. 2018. |
[23] | Szkwarko D, Hirsch-Moverman Y, Du Plessis L, Du Preez K, Carr C, Mandalakas AM. Child contact management in high tuberculosis burden countries: a mixed-methods systematic review. PLoS One. 2017; 12(8): e0182185. |
[24] | Rangaka MX, Cavalcante SC, Marais BJ, Thim S, Martinson NA, Swaminathan S, et al. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. The Lancet. 2015; 386(10010): 2344-53. |
[25] | House W. HIV care continuum initiative. Washington DC: White House. 2013. |
[26] | Cazabon D, Alsdurf H, Satyanarayana S, Nathavitharana R, Subbaraman R, Daftary A, et al. Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade. International Journal of Infectious Diseases. 2017; 56: 111-6. |
[27] | Rutherford ME, Ruslami R, Anselmo M, Alisjahbana B, Yulianti N, Sampurno H, et al. Management of children exposed to Mycobacterium tuberculosis: a public health evaluation in West Java, Indonesia. Bulletin of the World Health Organization. 2013; 91: 932-41A. |
[28] | Fox GJ, Barry SE, Britton WJ, Marks GB. Contact investigation for tuberculosis: a systematic review and meta-analysis. European Respiratory Journal. 2013; 41(1): 140-56. |
[29] | Acharya B, Acharya A, Gautam S, Ghimire SP, Mishra G, Parajuli N, et al. Advances in diagnosis of Tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis. Molecular biology reports. 2020; 47: 4065-75. |
[30] | de Lima Corvino DF, Shrestha S, Kosmin AR. Tuberculosis screening. 2017. |
[31] | Zawedde-Muyanja S, Manabe YC, Cattamanchi A, Castelnuovo B, Katamba A. Patient and health system level barriers to and facilitators for tuberculosis treatment initiation in Uganda: a qualitative study. BMC health services research. 2022; 22(1): 831. |
[32] | Rutherford ME, Hill PC, Triasih R, Sinfield R, van Crevel R, Graham SM. Preventive therapy in children exposed to Mycobacterium tuberculosis: problems and solutions. Tropical Medicine & International Health. 2012; 17(10): 1264-73. |
[33] | Matakanye H, Tshitangano TG, Mabunda JT, Maluleke TX. Knowledge, Beliefs, and Perceptions of TB and Its Treatment amongst TB Patients in the Limpopo Province, South Africa. International journal of environmental research and public health. 2021; 18(19). |
[34] | Masangalawe CT. Factors affecting the utilization of pulmonary tuberculosis contact tracing services in Mulanje and Chiradzulu district hospital in Malawi: The University of Zambia; 2017. |
[35] | Iberico Lozada MM. Factors Affecting Uptake of, and Adherence to, Treatment for Latent Tuberculosis Infection in Ventanilla, Peru. 2013. |
[36] | Rutherford ME, Ruslami R, Maharani W, Yulita I, Lovell S, Van Crevel R, et al. Adherence to isoniazid preventive therapy in Indonesian children: A quantitative and qualitative investigation. BMC Res Notes. 2012; 5: 7. |
APA Style
Beland, B., Bahadur, S., Inayatullah, Khan, A., Khan, M. (2024). Factors Influencing the Practices and Adherence of Isoniazid Prophylactic Therapy Among Under 5 Years Children in Tb Referral Units, Peshawar. Journal of Family Medicine and Health Care, 10(3), 51-59. https://doi.org/10.11648/j.jfmhc.20241003.12
ACS Style
Beland, B.; Bahadur, S.; Inayatullah; Khan, A.; Khan, M. Factors Influencing the Practices and Adherence of Isoniazid Prophylactic Therapy Among Under 5 Years Children in Tb Referral Units, Peshawar. J. Fam. Med. Health Care 2024, 10(3), 51-59. doi: 10.11648/j.jfmhc.20241003.12
AMA Style
Beland B, Bahadur S, Inayatullah, Khan A, Khan M. Factors Influencing the Practices and Adherence of Isoniazid Prophylactic Therapy Among Under 5 Years Children in Tb Referral Units, Peshawar. J Fam Med Health Care. 2024;10(3):51-59. doi: 10.11648/j.jfmhc.20241003.12
@article{10.11648/j.jfmhc.20241003.12, author = {Bakht Beland and Sher Bahadur and Inayatullah and Aqsa Khan and Munawar Khan}, title = {Factors Influencing the Practices and Adherence of Isoniazid Prophylactic Therapy Among Under 5 Years Children in Tb Referral Units, Peshawar }, journal = {Journal of Family Medicine and Health Care}, volume = {10}, number = {3}, pages = {51-59}, doi = {10.11648/j.jfmhc.20241003.12}, url = {https://doi.org/10.11648/j.jfmhc.20241003.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jfmhc.20241003.12}, abstract = {Importance: The under 5 years children of house hold contact with active tuberculosis cases is one of the main cause for the transmission of TB in pediatrics population, responsible for many complications and childhood mortality. Objective: To determine the factors influencing the practice and adherence of Isoniazid Prophylactic Therapy (IPT) among under 5 years children of house hold with cases of active pulmonary tuberculosis. Design: The study’s design was cross sectional. Setting: This study was conducted in TB referral units of the National Tuberculosis Control Program in Peshawar City. Participants: The study participants included patients with sputum-positive pulmonary TB having at least one under-5 years’ child in their household. Secondly, the doctors who were directly dealing with TB patients for diagnosis and treatments in referral units of the respective hospitals. Results: Most of the patients reported that doctors neither got some information about the under-5 years' children at their family nor to bring them for TB screening. Just 13.2% patients (36 out of 273) conceded that doctors mentioned them for prophylactic treatment with Isoniazid (INH) medication for their contact positive under-5years children. But only 4 of these 36 patients [(11.11%) 1.46%of the aggregate] completed the IPT course for their under-5 year children for 6 months duration. (Table 2) All the doctors claimed that they got information about the presence of under five years household contact in the family of TB patients. While the majority of the doctors/physicians (80%) had recognized that they neither requested the patients for screening from their family contact nor to give INH medication for their prophylaxis. This study showed that the practice of IPT was 13.2% and the adherence rate was just 11.11%, and the main factors for this poor result were poor healthcare system, lack of awareness, financial constraint and attitude of the patients. Conclusion: This study concludes that the extremely poor practice and adherence to isoniazid prophylactic therapy by doctors and patients in TB referral units in Peshawar city for under-5-year-old children of households with active tuberculosis patients was primarily caused by a lack of awareness, financial constraints, patient attitudes, and an inefficient healthcare system. }, year = {2024} }
TY - JOUR T1 - Factors Influencing the Practices and Adherence of Isoniazid Prophylactic Therapy Among Under 5 Years Children in Tb Referral Units, Peshawar AU - Bakht Beland AU - Sher Bahadur AU - Inayatullah AU - Aqsa Khan AU - Munawar Khan Y1 - 2024/09/06 PY - 2024 N1 - https://doi.org/10.11648/j.jfmhc.20241003.12 DO - 10.11648/j.jfmhc.20241003.12 T2 - Journal of Family Medicine and Health Care JF - Journal of Family Medicine and Health Care JO - Journal of Family Medicine and Health Care SP - 51 EP - 59 PB - Science Publishing Group SN - 2469-8342 UR - https://doi.org/10.11648/j.jfmhc.20241003.12 AB - Importance: The under 5 years children of house hold contact with active tuberculosis cases is one of the main cause for the transmission of TB in pediatrics population, responsible for many complications and childhood mortality. Objective: To determine the factors influencing the practice and adherence of Isoniazid Prophylactic Therapy (IPT) among under 5 years children of house hold with cases of active pulmonary tuberculosis. Design: The study’s design was cross sectional. Setting: This study was conducted in TB referral units of the National Tuberculosis Control Program in Peshawar City. Participants: The study participants included patients with sputum-positive pulmonary TB having at least one under-5 years’ child in their household. Secondly, the doctors who were directly dealing with TB patients for diagnosis and treatments in referral units of the respective hospitals. Results: Most of the patients reported that doctors neither got some information about the under-5 years' children at their family nor to bring them for TB screening. Just 13.2% patients (36 out of 273) conceded that doctors mentioned them for prophylactic treatment with Isoniazid (INH) medication for their contact positive under-5years children. But only 4 of these 36 patients [(11.11%) 1.46%of the aggregate] completed the IPT course for their under-5 year children for 6 months duration. (Table 2) All the doctors claimed that they got information about the presence of under five years household contact in the family of TB patients. While the majority of the doctors/physicians (80%) had recognized that they neither requested the patients for screening from their family contact nor to give INH medication for their prophylaxis. This study showed that the practice of IPT was 13.2% and the adherence rate was just 11.11%, and the main factors for this poor result were poor healthcare system, lack of awareness, financial constraint and attitude of the patients. Conclusion: This study concludes that the extremely poor practice and adherence to isoniazid prophylactic therapy by doctors and patients in TB referral units in Peshawar city for under-5-year-old children of households with active tuberculosis patients was primarily caused by a lack of awareness, financial constraints, patient attitudes, and an inefficient healthcare system. VL - 10 IS - 3 ER -